Stefan Stojković

ORCID: 0000-0002-4285-5416
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • IL-33, ST2, and ILC Pathways
  • Mechanical Engineering and Vibrations Research
  • Engineering Structural Analysis Methods
  • Atrial Fibrillation Management and Outcomes
  • Eosinophilic Esophagitis
  • Cardiac Arrhythmias and Treatments
  • Cardiac pacing and defibrillation studies
  • Electronic Packaging and Soldering Technologies
  • MicroRNA in disease regulation
  • Cardiac Imaging and Diagnostics
  • Coronary Interventions and Diagnostics
  • Heart Failure Treatment and Management
  • Protease and Inhibitor Mechanisms
  • Cardiovascular Disease and Adiposity
  • Mechanical stress and fatigue analysis
  • Extracellular vesicles in disease
  • Circular RNAs in diseases
  • Atherosclerosis and Cardiovascular Diseases
  • Cardiac electrophysiology and arrhythmias
  • Cardiovascular Function and Risk Factors
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Engineering Applied Research
  • GDF15 and Related Biomarkers
  • Cerebrovascular and Carotid Artery Diseases
  • Platelet Disorders and Treatments

Medical University of Vienna
2016-2025

Univerzitetski Klinički Centar Srbije
2024

Ludwig Boltzmann Institute for Cancer Research
2021

Ludwig Boltzmann Institute for Digital Health and Prevention
2021

Centar za Promociju Nauke
2018-2020

Ludwig Boltzmann Cluster for Cardiovascular Research
2014-2018

Private University in the Principality of Liechtenstein
2018

Federal Almazov North-West Medical Research Centre
2018

Union Hospital
2017

Universität für Weiterbildung Krems
2017

Jonathan P. Piccini Valeria Caso Stuart J. Connolly Keith A.A. Fox Jonas Oldgren and 95 more W. Schuyler Jones Diana A. Gorog Václav Durdil Thomas Viethen Christoph Neumann Hardi Mundl Manesh R. Patel Johann Auer Martin Hubauer Sead Pandzic Eva Preishuber Carina Primus-Grabscheit Dietmar Reitgruber Florian Schmalzer Christopher Adlbrecht Andreas Schober Johannes Hajos Christoph Keil Alexandra Schratter Matthias Frick Magdalena Benda Maximilian Mächler Beatrix Mutschlechner Christoph H. Saely Lukas Sprenger Michael Lichtenauer Miriam Eber Uta C. Hoppe Tobias Kolbitsch Peter Jirak Moritz Mirna Robert Schönbauer Jutta Bergler‐Klein Christian Hengstenberg Stefan Stojković Douglas S. Scherr M Manninger-Wünscher Ursula Rohrer Markus Stühlinger Wilfried Schgoer Jana M. Schwarzl Helmut Pürerfellner Michael Derndorfer Christian Ebner Veronika Eder Γεώργιος Κόλλιας Thomas Sturmberger Stefan Sieghartsleitner Johan Vijgen Peter Koopman Karl Dujardin Wim Anné Michel de Ceuninck René Tavernier Mattias Duytschaever Sébastien Knecht Luc Missault Yves Vandekerckhove Tom Rossenbacker Bavo Ector Filip Charlier Philippe Debruyne Willem Dewilde Luc Janssens John Roosen Bart Vankelecom Hein Heidbüchel Michiel Delesie G. M. M. Vervoort Hans Rombouts Thomas Vanassche Matthias M. Engelen Peter Verhamme Rik Willems Christian Constance Nicolas Pranno Jafna L. Cox Iqbal Bata Laurent Macle Martín Aguilar J. Tourigny Marc Dubuc Katia Dyrda Peter G. Guerra Paul Khairy Blandine Mondésert Léna Rivard Denis Roy Rafik Tadros Mario Talajic Bernard Thibault Isabelle Nault L. Blier Jean Champagne Franck Molin

10.1016/s0140-6736(22)00456-1 article EN The Lancet 2022-04-01

Abstract Tissue factor (TF) is the primary trigger of coagulation. Elevated levels TF are found in atherosclerotic plaques and leads to thrombus formation when released upon plaque rupture. Interleukin (IL)-33 was previously shown induce angiogenesis inflammatory activation endothelial cells (ECs). Here, we investigated impact IL-33 on human ECs, as a possible new link between inflammation induced mRNA protein umbilical vein ECs coronary artery ECs. IL-33-induced expression ST2-...

10.1038/srep25171 article EN cc-by Scientific Reports 2016-05-04

Background: Pulsed field ablation [PFA] is a novel technique for pulmonary vein isolation [PVI] in patients with paroxysmal and persistent atrial fibrillation. However, data the efficacy safety of PFA left substrate modification using single shot system, long-standing fibrillation [AF] macro- as well micro-reentrant tachycardia [LAMRT], are scarce. Here, we provide small, single-center case series regarding single-shot system. Methods: Nine AF LAMRT underwent redo-PVI Patients were...

10.3390/jcm14061891 article EN Journal of Clinical Medicine 2025-03-11

Neutrophil gelatinase-associated lipocalin (NGAL), an acute phase protein released by neutrophils, has been described as biomarker of inflammatory states. Type 2 diabetes mellitus (T2DM) is characterized increased inflammation and elevated risk for embolization carotid artery stenosis (CAS). We aimed to explore the role NGAL systemically in plaques diabetics undergoing endarterectomy. Moreover, potential anti-inflammatory effect metformin on was addressed diabetics. Serum matrix...

10.1186/s12933-017-0579-6 article EN cc-by Cardiovascular Diabetology 2017-08-08

Neutrophil gelatinase associated lipocalin (NGAL) is expressed in atherosclerotic lesions and was recently implicated the pathogenesis of cardiovascular pathologies. Statins are known to exert stabilizing effects on plaque. The aims our study were (1) investigate association serum NGAL metalloproteinase (MMP)-9/NGAL complex with vulnerability plaque, (2) reveal statin treatment circulating MMP-9/NGAL levels patients carotid artery stenosis.We examined blood samples from 136 stenosis by...

10.1515/cclm-2017-0156 article EN Clinical Chemistry and Laboratory Medicine (CCLM) 2017-06-26

Monocytes and monocyte-derived microvesicles (MVs) are the main source of circulating tissue factor (TF). Increased monocyte TF expression increased levels procoagulant MVs contribute to formation a prothrombotic state in patients with cardiovascular disease. Interleukin (IL)-33 is pro-inflammatory cytokine involved atherosclerosis other inflammatory diseases, but its role regulating thrombosis still unclear. The aim present study was investigate effects IL-33 on properties human monocytes...

10.1160/th16-10-0784 article EN Thrombosis and Haemostasis 2017-01-01

Endothelial cells (ECs) are major modulators of hemostasis by expressing and releasing pro- anticoagulant mediators into the circulation. Previous studies showed that cultured ECs release procoagulant cell culture supernatants as evidenced reduction viscoelastic clotting time. This effect was reversed with an anti-tissue factor antibody. Here, we aimed to investigate whether tissue (TF) released endothelial-derived extracellular vesicles (EVs) which portion displays most prominent...

10.1038/s41598-017-03159-0 article EN cc-by Scientific Reports 2017-06-12

Macrophages are versatile immune cells capable of polarizing into functional subsets depending on environmental stimulation. In atherosclerotic lesions, proinflammatory polarized macrophages associated with symptomatic plaques, whereas Th2 (T-helper cell type 2) cytokine-polarized inversely related disease progression. To establish a cause for these observations, we analyzed extracellular matrix degradation phenotypes in macrophages.

10.1161/atvbaha.117.309383 article EN cc-by-nc-nd Arteriosclerosis Thrombosis and Vascular Biology 2017-08-18

Growth differentiation factor (GDF)-15 and soluble ST2 (sST2) are established prognostic markers in acute chronic heart failure. Assessment of these biomarkers might improve arrhythmic risk stratification patients with non-ischaemic, dilated cardiomyopathy (DCM) based on left ventricular ejection fraction (LVEF). We studied the value GDF-15 sST2 for prediction death (AD) all-cause mortality DCM. prospectively enrolled 52 DCM LVEF ≤ 50%. Primary end-points were time to AD or resuscitated...

10.1111/jcmm.13540 article EN cc-by Journal of Cellular and Molecular Medicine 2018-02-04

Neutrophil extracellular traps (NETs) are supposed to play a central role in atherothrombosis. We measured circulating citrullinated histone H3 (H3Cit) and cell-free DNA (cfDNA), which serve as surrogate markers of NET formation, 79 patients with peripheral artery disease (PAD) following infrainguinal angioplasty stent implantation. Analysis cfDNA H3Cit was performed using Quant-iT™ PicoGreen® dsDNA Assay Kit or an ELISA, respectively. Within two years follow-up, the primary endpoint defined...

10.3390/jcm9020304 article EN Journal of Clinical Medicine 2020-01-22

Macrophages are versatile cells that can be polarized by the tissue environment to fulfill required needs. Proinflammatory polarization is associated with increased degradation and propagation of inflammation whereas alternative within a Th2 cytokine wound healing angiogenesis. To understand if macrophages lead procoagulant macrophage subset we human monocyte derived proinflammatory an activation state. Alternative interleukin-4 IL-13 led phenotype characterized factor (TF) production...

10.3324/haematol.2019.220210 article EN cc-by-nc Haematologica 2020-01-23

Summary Interleukin (IL)-33, a member of the IL-1 family cytokines, is involved in various inflammatory conditions targeting amongst other cells endothelium. Besides regulating maturation and functions myeloid cells, granulocyte macrophage-colony stimulating factor (GM-CSF) macrophage-CSF (M-CSF) have been shown to play role such pathologies too. It was aim our study investigate possible influence IL-33 on GM-CSF M–CSF production by human endothelial cells. IL-33, but not IL-18 or IL-37,...

10.1160/th15-12-0917 article EN Thrombosis and Haemostasis 2016-03-01

Perioperative oxygen (O2) therapy can cause hyperoxia. Extreme hyperoxia injure the cardiovascular system and remote organs.Our primary objective was to test hypothesis that exposure moderate will induce injury human umbilical vein endothelial cells (HUVECs), a model for studying vascular endothelium under controlled conditions.In-vitro cell culture study.Department of Anaesthesia, General Intensive Care Pain Management, Medical University Vienna, Austria. Study period from beginning October...

10.1097/eja.0000000000000593 article EN European Journal of Anaesthesiology 2017-01-19

Inflammation is a key process during atherosclerotic lesion development and propagation. Recent evidence showed clearly that especially the inhibition of interleukin (IL)-1β reduced adverse events in human patients. Fatty acid oxidation (FAO) was previously demonstrated to interact with NOD-, LRR- pyrin domain-containing protein 3 (NLRP3) pathway which required for mature IL-1β secretion. To understand possible anti-inflammatory properties FAO inhibition, we tested effect pharmacological...

10.1016/j.bcp.2021.114634 article EN cc-by Biochemical Pharmacology 2021-05-28
Coming Soon ...